Antibody-immunotoxin Conjugate Using FcBP-mediated Photoconjugation to Treat Cancer

Background/Aim: Cytotoxic payload conjugation to antibodies efficiently suppresses tumors and contributes to the improvement of cancer survival. In our previous study, c-Kit targeting antibody–drug conjugate (2G4-DM1) with DM1, a microtubule inhibitor, efficiently suppressed tumor growth. However, s...

Full description

Saved in:
Bibliographic Details
Published in:Anticancer research 2022-07, Vol.42 (7), p.3453-3461
Main Authors: KIM, KWANG-HYEOK, PARK, JISOO, KIM, JIN-OCK, KO, HAN-JIK, PARK, SANG GYU
Format: Article
Language:English
Subjects:
Amino acids
Anion exchange
Anion exchanging
Antibodies
Biocompatibility
c-Kit protein
Cancer
Conjugates
Conjugation
Cytotoxicity
E coli
Exotoxin A
Immunotoxins
Inhibitors
Phenylalanine
Protein biosynthesis
Protein synthesis
Toxicity
Tumors
Xenografts
Xenotransplantation
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background/Aim: Cytotoxic payload conjugation to antibodies efficiently suppresses tumors and contributes to the improvement of cancer survival. In our previous study, c-Kit targeting antibody–drug conjugate (2G4-DM1) with DM1, a microtubule inhibitor, efficiently suppressed tumor growth. However, slow-growing c-Kit-positive tumors, such as GIST-48, did not efficiently respond to DM1. In this study, we aimed to treat tumors using 2G4 immunotoxin with Pseudomonas exotoxin A (PE) as a payload. Materials and Methods: Modified FcBP-PE24 containing p-benzoyl-L-phenylalanine, unnatural amino acid, was expressed in E. coli and purified. Then, photoconjugation of 2G4 antibody and FcBP-PE24 at 365 nm was carried out and 2G4 immunotoxin was purified using anion exchange chromatography. In vitro cytotoxicity of 2G4 immunotoxins was assessed in HMC-1.2, GIST-48, and MDA-MB-453 cells. Then, in vivo efficacy analysis was performed using C.B-17 SCID mice. Results: 2G4 immunotoxin efficiently induced cytotoxicity in 2G4-DM1–resistant HMC-1.2 and GIST-48 cells by inhibiting protein synthesis but not in c-Kit–negative MDA-MB-453 cells. The results showed ~200-fold or more increase in cytotoxicity against c-Kit–positive cells compared to IC50 of 2G4-DM1. In addition, 2G4 immunotoxin suppressed tumor growth in the in vivo xenograft mouse model. Conclusion: 2G4 immunotoxins could be an alternative therapeutic strategy for microtubule inhibitor– resistant cancer cells.
ISSN:0250-7005
1791-7530
DOI:10.21873/anticanres.15832